NL-OMON42072撤回不适用
Phenomics and Genomics of Clozapine Pharmacotherapy - CLOZ
niversitair Medisch Centrum Utrecht0 个研究点目标入组 4,000 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 入组人数
- 4,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •-he/she currently uses clozapine or is about to initiate a treatment of clozapine
- •-he/she has received a diagnosis of schizophrenia or schizoaffective disorder, either clinician-rated based on DSM-IV or 5 criteria or according to a (semi-)structured interview
- •-his/her age must be >=18 years old
- •-he/she must be able to speak and read the Dutch language
- •-he/she must understand the information provided about the study and express a willingness to participate
排除标准
- •- admission to a psychiatric unit involuntarily in the context of an *inbewaringstelling* (IBS) or *rechterlijke machtiging* (RM)
研究者
相似试验
招募中
不适用
Phenomics and Genomics of Clozapine Pharmacotherapy - New Clozapine UsersPsychosispsychotic disorders10039628NL-OMON50475niversitair Medisch Centrum Utrecht200
招募中
不适用
A better understanding of the response and side effect of clozapine useSchizophrenia,schizophreniform and schizoaffective disorderClozapine, psychotic disordersNL-OMON20290niversity Medical Center Utrecht60
招募中
不适用
Phenomics & Genomics of Clozapine Pharmacotherapy - Current Userspsychosispsychotic disorders10039628NL-OMON50518niversitair Medisch Centrum Utrecht2,778
招募中
不适用
Phenomics & Genomics of Clozapine Pharmacotherapy: To a better understanding of the backgrounds of clozapine useGenetics of clozapine use because of schizophrenia, schizo-affective disorder, schizophreniform disorderNL-OMON20386Dr. J. Luykx2,500
进行中（未招募）
1 期
Biomarkers in patients with Schizophrenia responding to Clozapine treatmentMedDRA version: 21.1 Level: LLT Classification code 10009134 Term: Chronic schizophrenia System Organ Class: 100000004873schizophreniaEUCTR2019-003128-19-DKPsykiatrisk Center Glostrup200